Benoxinate Hydrochloride is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982. Its therapeutic use is listed as anesthetics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Benoxinate hydrochloride, Cebesine, Conjuncain, Lacrimin and Novesina. Its PubChem CID is 6420040.
Oxybuprocaine hydrochloride
| CAS No | 5987-82-6 |
|---|---|
| Molecular Formula | C17H29ClN2O3 |
| Molecular Weight | 344.9 g/mol |
| Synonyms | 2-(diethylamino)ethyl 4-amino-3-butoxybenzoate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Benoxinate Hydrochloride is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982. Its therapeutic use is listed as anesthetics.
The listed CAS number is 5987-82-6.
The listed molecular formula is C17H29ClN2O3.
The listed molecular weight is 344.9 g/mol.
2-(diethylamino)ethyl 4-amino-3-butoxybenzoate;hydrochloride.
The source lists Benoxinate hydrochloride, Cebesine, Conjuncain, Lacrimin and Novesina.